» Articles » PMID: 32183150

Basal-Type Breast Cancer Stem Cells Over-Express Chromosomal Passenger Complex Proteins

Overview
Journal Cells
Publisher MDPI
Date 2020 Mar 19
PMID 32183150
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Aim: In the present paper we analyzed the transcriptome of CSCs (Cancer Stem Cells), in order to find defining molecular processes of breast cancer. (2) Methods: We performed RNA-Seq from CSCs isolated from the basal cell line MDA-MB-468. Enriched processes and networks were studied using the IPA (Ingenuity Pathway Analysis) tool. Validation was performed with qRT-PCR and the analysis of relevant genes was evaluated by overexpression, flow cytometry and in vivo zebrafish studies. Finally, the clinical relevance of these results was assessed using reported cohorts. (3) Results: We found that CSCs presented marked differences from the non-CSCs, including enrichment in transduction cascades related to stemness, cellular growth, proliferation and apoptosis. Interestingly, CSCs overexpressed a module of co-regulated Chromosomal Passenger Proteins including BIRC5 (survivin), INCENP and AURKB. Overexpression of BIRC5 increased the number of CSCs, as assessed by in vitro and in vivo zebrafish xenotransplant analyses. Analysis of previously published cohorts showed that this co-regulated module was not only overexpressed in basal breast tumors but also associated with relapse-free and overall survival in these patients. (4) Conclusions: These results underline the importance of Cancer Stem Cells in breast cancer progression and point toward the possible use of chromosomal passenger proteins as prognostic factors.

Citing Articles

Cancer Stem Cells from Definition to Detection and Targeted Drugs.

Ruszkowska-Ciastek B, Kwiatkowska K, Marques-da-Silva D, Lagoa R Int J Mol Sci. 2024; 25(7).

PMID: 38612718 PMC: 11011379. DOI: 10.3390/ijms25073903.


KRAB-ZFPs and cancer stem cells identity.

Olechnowicz A, Oleksiewicz U, Machnik M Genes Dis. 2023; 10(5):1820-1832.

PMID: 37492743 PMC: 10363567. DOI: 10.1016/j.gendis.2022.03.013.


Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine.

Wawruszak A, Okon E, Dudziak K Med Sci Monit. 2023; 29:e940550.

PMID: 37393427 PMC: 10332173. DOI: 10.12659/MSM.940550.


Testing the Anticancer Effect of Matcha Using Zebrafish as an Animal Model.

Sokary S, Zakaria Z, Bawadi H, Al-Asmakh M Nutrients. 2023; 15(10).

PMID: 37242252 PMC: 10220593. DOI: 10.3390/nu15102369.


Survivin (BIRC5) Peptide Vaccine in the 4T1 Murine Mammary Tumor Model: A Potential Neoadjuvant T Cell Immunotherapy for Triple Negative Breast Cancer: A Preliminary Study.

Burkholz S, Herst C, Carback R, Harris P, Rubsamen R Vaccines (Basel). 2023; 11(3).

PMID: 36992227 PMC: 10051918. DOI: 10.3390/vaccines11030644.


References
1.
Hu Y, Smyth G . ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009; 347(1-2):70-8. DOI: 10.1016/j.jim.2009.06.008. View

2.
Nguyen H, Ravid K . Tetraploidy/aneuploidy and stem cells in cancer promotion: The role of chromosome passenger proteins. J Cell Physiol. 2005; 208(1):12-22. DOI: 10.1002/jcp.20565. View

3.
Asiedu M, Ingle J, Behrens M, Radisky D, Knutson K . TGFbeta/TNF(alpha)-mediated epithelial-mesenchymal transition generates breast cancer stem cells with a claudin-low phenotype. Cancer Res. 2011; 71(13):4707-19. PMC: 3129359. DOI: 10.1158/0008-5472.CAN-10-4554. View

4.
Choi H, Kim J, Kim S, Lee D . Disruption of the NF-κB/IL-8 Signaling Axis by Sulconazole Inhibits Human Breast Cancer Stem Cell Formation. Cells. 2019; 8(9). PMC: 6770215. DOI: 10.3390/cells8091007. View

5.
Li B, Dewey C . RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011; 12:323. PMC: 3163565. DOI: 10.1186/1471-2105-12-323. View